State of Alaska Department of Revenue’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

State of Alaska Department of Revenue’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-41,511	Closed	-$4.8M	–	1628
2023 Q3	$4.8M	Hold	41,511	–	–	0.06%	364
2023 Q2	$4.27M	Sell	41,511 -23,645	-36%	-$2.49M	0.05%	411
2023 Q1	$7.11M	Buy	65,156 +650	+1%	+$71.8K	0.08%	267
2022 Q4	$7.34M	Sell	64,506 -4,760	-7%	-$395K	0.09%	255
2022 Q3	$4.29M	Sell	69,266 -11,980	-15%	-$837K	0.06%	369
2022 Q2	$6.48M	Sell	81,246 -3,165	-4%	-$300K	0.08%	284
2022 Q1	$8.88M	Sell	84,411 -8,905	-10%	-$868K	0.09%	241
2021 Q4	$10.1M	Sell	93,316 -12,985	-12%	-$1.42M	0.1%	232
2021 Q3	$11.6M	Sell	106,301 -7,763	-7%	-$806K	0.12%	194
2021 Q2	$10.7M	Buy	+114,064	New	+$10.5M	0.11%	221
2021 Q1	–	Sell	-4,225	Closed	-$309K	–	1698
2020 Q4	$309K	Buy	4,225 +413	+11%	+$30.7K	﹤0.01%	1521
2020 Q3	$296K	Sell	3,812 -2,086	-35%	-$144K	﹤0.01%	1442
2020 Q2	$327K	Hold	5,898	–	–	﹤0.01%	1412
2020 Q1	$174K	Buy	+5,898	New	+$200K	﹤0.01%	1475

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

State of Alaska Department of Revenue's HZNP Position: Q4 2023 in Review

State of Alaska Department of Revenue sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 41,511 shares — an estimated $4.8M sold.

State of Alaska Department of Revenue first reported a position in HZNP in Q1 2020 and held it in 14 quarters. The position peaked at $11.6M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

State of Alaska Department of Revenue reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
State of Alaska Department of Revenue sold 41,511 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $4.8M.
State of Alaska Department of Revenue first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2020 and held it in 14 quarters.
State of Alaska Department of Revenue's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $11.6M in Q3 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on State of Alaska Department of Revenue's 13F filing for Q4 2023, filed 19 Jan 2024.